Cerner (CERN) Peer Comparison

$94.92

$-0.05 (-0.05%)

As on 07-Jun-2022 16:00EDT

Market cap

$27,916 Mln

Revenue (TTM)

$5,807 Mln

P/E Ratio

48.1

P/B Ratio

7.1

Div. Yield

1.1 %

Edit

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Market cap ($ Mln)	27,916	231
Revenue ($ Mln)	5,807	--
Net Profit ($ Mln)	589.47	-63.14
Net Margin (%)	10.17	-332,336.84
RoE (%)	15.22	-92.50
Price to Earnings	48.06	--
Price-To-Book	7.07	4.19

Income Statement ($ Mln)

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Operating Revenue	5,764.82	0.00
Cost of Revenue	1,001.02	--
Gross Profit	4,763.81	--
Operating Expenses	4,055.53	61.47
Operating Profit (EBIT)	708.28	-61.47
Other Income	-8.82	--
Profit before Tax	699.46	-61.41
Provision for Tax	143.86	--
Profit after Tax (Net Income)	555.60	-61.41
Minority Interest	--	--
Consolidated Profit	555.60	-61.41

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Shareholder's Funds	3,680.46	69.46
Minority Interest	--	--
Non-Current Liabilities	2,127.44	0.00
Current Liabilities	1,626.26	9.38
Total Liabilities	7,434.16	78.84

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Non-Current Assets	4,984.70	4.88
Current Assets	2,449.45	73.96
Total Assets	7,434.16	78.84
Total Debt*	1,836.26	--
Net Current Assets	823.20	64.58

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Cash From Operating Activities	1,771.68	-53.72
Cash Flow from Investing Activities	-729.83	61.19
Cash from Financing Activities	-1,054.85	0.15
Net Cash Inflow / Outflow	-25.77	--

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
ROCE (%)	9.61	-63.09
ROE (%)	13.61	-63.09
ROA (%)	7.43	-57.95
EBIT Margin (%)	--	--
Net Margin (%)	9.65	--
Cash Profit Margin (%)	--	--

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Revenue Growth (%)	0.05	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	-28.78	-66.37
EPS Growth (%)	-0.27	0.24
Book Value Growth (%)	--	--

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Price / Earnings	50.31	-1.03
Price / Book Value	7.60	0.91
Dividend Yield (%)	--	--
EV/EBITDA	19.80	0.13
Market Cap ($ Cr)	--	--

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Debt to Equity	0.50	--
Short term debt to equity ratio	0.06	--
Current Ratio	1.51	7.89
Quick Ratio	1.49	--
Interest Coverage	17.09	--

	Cerner (CERN)	Checkmate Pharmaceuticals (CMPI)
Debtors to sales (%)	20.15	--
Asset Turnover	0.77	0.00
Receivable days	73.81	--
Inventory Days	9.34	--
Payable days	103.14	--
Cash Conversion Cycle	-19.99	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.